Mark Auerbach
CIK 1018007 · last filed 2023-08-31
Mark Auerbach is a corporate insider who has filed 35 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for PRDS, was dated Aug 31, 2023.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ASMB price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
GRAND PRAIRIE, TX 75050
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PARDES BIOSCIENCES, INC. (PRDS) Delisted | Director | 0 | $2.16 | $0 | $0 | 4 | 2023-08-31 |
| ASMB | Director | — | $19.67 | — | $0 | 7 | 2019-05-17 |
| RCS Capital Corp (RCAP) Delisted | Director | 127,961 | — | — | $0 | 3 | 2015-12-28 |
| ASSEMBLY BIOSCIENCES, INC. (VTUS) Delisted | Director | — | — | — | $0 | 4 | 2014-07-14 |
| Neuro-Hitech, Inc. (NHPI) Delisted | Director | — | — | — | $0 | 4 | 2008-01-14 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-08-31 | PARDES BIOSCIENCES, INC. (PRDS) Delisted | Mixed | −70,390 | $0 | EDGAR |
| 2023-06-02 | PARDES BIOSCIENCES, INC. (PRDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | PARDES BIOSCIENCES, INC. (PRDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-28 | PARDES BIOSCIENCES, INC. (PRDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-17 | ASMB | Grant (A) | — | $0 | EDGAR |
| 2018-06-01 | ASMB | Grant (A) | — | $0 | EDGAR |
| 2017-06-05 | ASMB | Grant (A) | — | $0 | EDGAR |
| 2016-06-03 | ASMB | Grant (A) | — | $0 | EDGAR |
| 2015-12-28 | RCS Capital Corp (RCAP) Delisted | Disp (D) | −20,346 | -$229.5K | EDGAR |
| 2015-08-28 | RCS Capital Corp (RCAP) Delisted | Grant (A) | +99,206 | $250.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.